Profile for Outlook Therapeutics Inc. (OTLK)

$ 1.40   0.09 (+6.87%) Volume: 167.84k 3:59 PM EDT Oct 15, 2019
After Hours:  $ 1.43   0.03 (+2.14%) Volume: 17.97k 5:30 PM EDT Oct 15, 2019
Business Description:
Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.
Address: 7 Clarke Drive, Cranbury, NJ, USA, 08512
Telephone: +1 609 619-3990 Website: https://www.outlooktherapeutics.com
Facsimile: +1 609 228-4330 Email: [email protected]
Details
CEO: N/A
Employees: 56 Market Cap: 39.53m
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology
Industry Classifications
Sector: Healthcare CIK: 1649989
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)